GE Capital invests in R2 Technology

Article

R2 Technology strengthened its relationship with GE last month with the signing of an $11 million financing agreement led by GE's financing arm, GE Capital. The financing will be used for working capital purposes as R2 prepares for an initial public

R2 Technology strengthened its relationship with GE last month with the signing of an $11 million financing agreement led by GE's financing arm, GE Capital. The financing will be used for working capital purposes as R2 prepares for an initial public offering that the company plans to launch some time this year. R2 did not disclose what percentage of the Los Altos, CA, company GE Capital now owns.

R2 has developed ImageChecker M1000, a computer-aided diagnosis product for flagging suspicious areas on mammograms. The product is awaiting Food and Drug Administration approval. R2 signed an agreement with GE Medical Systems in April that gives the Milwaukee company rights to the product when sold with full-field digital mammography systems (SCAN 4/29/98). The financing deal with GE Capital was not directly related to the GEMS agreement, according to an R2 spokesperson.

Newsletter

Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.

Recent Videos
SNMMI: Emerging PET Insights on Neuroinflammation with Progressive Apraxia of Speech (PAOS) and Parkinson-Plus Syndrome
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
Related Content
© 2025 MJH Life Sciences

All rights reserved.